0001127602-12-019748.txt : 20120611 0001127602-12-019748.hdr.sgml : 20120611 20120611144256 ACCESSION NUMBER: 0001127602-12-019748 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120608 FILED AS OF DATE: 20120611 DATE AS OF CHANGE: 20120611 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brykman Kurt Arthur CENTRAL INDEX KEY: 0001303069 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21244 FILM NUMBER: 12900211 MAIL ADDRESS: STREET 1: C/O PAREXEL INTERNATIONAL CORPORATION STREET 2: 195 WEST STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PAREXEL INTERNATIONAL CORP CENTRAL INDEX KEY: 0000799729 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 042776269 STATE OF INCORPORATION: MA FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 195 WEST ST CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 7814879900 MAIL ADDRESS: STREET 1: 195 WEST ST CITY: WALTHAM STATE: MA ZIP: 02451 4 1 form4.xml PRIMARY DOCUMENT X0305 4 2012-06-08 0000799729 PAREXEL INTERNATIONAL CORP PRXL 0001303069 Brykman Kurt Arthur PAREXEL INTERNATIONAL CORPORATION 195 WEST STREET WALTHAM MA 02451 1 President, PACE and PCMS Common Stock 2012-06-08 4 M 0 15800 12.55 A 104017 D Common Stock 2012-06-08 4 S 0 26800 26.66 D 77217 D Stock Option (Right to Buy) 12.55 2012-06-08 4 M 0 15800 0 D 2017-09-09 Common Stock 15800 15800 D The reported sale was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the reporting person. This transaction was executed in multiple trades through a trade order executed by a broker-dealer at prices ranging from $26.49- $26.97. The price reported in this column reflects the weighted average sale price. For all transactions reported on this Form 4 utilizing a weighted average sale price, the reporting person will provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each price. Options become exercisable in increments of 25% of the total shares granted commencing on the first anniversary of the date of grant. /s/Douglas A. Batt, Attorney-in-fact 2012-06-11